Amendment and Modification Agreement Sample Contracts
EXHIBIT 10.3 FOURTH AMENDMENT AND MODIFICATION AGREEMENT FOURTH AMENDMENT AND MODIFICATION AGREEMENT dated as of April 30, 1999 (this "Amendment") by and among HADCO CORPORATION, a Massachusetts corporation (the "Borrower"); the direct and indirect...Amendment and Modification Agreement • June 7th, 1999 • Hadco Corp • Printed circuit boards
Standard Contracts
AMENDMENT AND MODIFICATION AGREEMENT TO TRANSACTION DOCUMENTSAmendment and Modification Agreement • June 10th, 2016 • Kadmon Holdings, LLC • Pharmaceutical preparations • New York
This AMENDMENT AND MODIFCATION AGREEMENT dated as of October 2, 2014 (this “Amendment”) to: (i) that certain Asset Purchase Agreement by and between Kadmon Pharmaceuticals, LLC (“Kadmon”) and AbbVie Bahamas, Ltd. (the “APA”); (ii) that certain License Agreement by and between Kadmon and AbbVie Inc. (as amended by that certain Amendment No.1 to the License Agreement dated May 22, 2014, the “License Agreement”); and (iii) that certain Supply Agreement by and between Kadmon and AbbVie Bahamas, Ltd. (the “Supply Agreement”), each dated June 17, 2013, is made by and between Kadmon, on the one hand, and AbbVie Bahamas, Ltd. and AbbVie Inc., (together, “AbbVie”), on the other hand. Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Transaction Documents (as defined below).
THIRD AMENDMENT AND MODIFICATION AGREEMENTAmendment and Modification Agreement • January 9th, 2015 • Mistras Group, Inc. • Services-engineering services • New York
THIS THIRD AMENDMENT AND MODIFICATION AGREEMENT (hereinafter referred to as this “Third Amendment”) is made this ______ day of October, 2014, by and among
AMENDMENT AND MODIFICATION AGREEMENT TO TRANSACTION DOCUMENTSAmendment and Modification Agreement • March 18th, 2016 • Kadmon Holdings, LLC • Pharmaceutical preparations • New York
This AMENDMENT AND MODIFCATION AGREEMENT dated as of October 2, 2014 (this “Amendment”) to: (i) that certain Asset Purchase Agreement by and between Kadmon Pharmaceuticals, LLC (“Kadmon”) and AbbVie Bahamas, Ltd. (the “APA”); (ii) that certain License Agreement by and between Kadmon and AbbVie Inc. (as amended by that certain Amendment No.1 to the License Agreement dated May 22, 2014, the “License Agreement”); and (iii) that certain Supply Agreement by and between Kadmon and AbbVie Bahamas, Ltd. (the “Supply Agreement”), each dated June 17, 2013, is made by and between Kadmon, on the one hand, and AbbVie Bahamas, Ltd. and AbbVie Inc., (together, “AbbVie”), on the other hand. Capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Transaction Documents (as defined below).
SIXTH AMENDMENT AND MODIFICATION AGREEMENTAmendment and Modification Agreement • April 3rd, 2012 • Maidenform Brands, Inc. • Retail-department stores • New York
THIS SIXTH AMENDMENT AND MODIFICATION AGREEMENT (hereinafter referred to as this “Sixth Amendment”) is made this 28th day of March, 2012, by and among
